+91-22-489139092019 ஆம் ஆண்டிற்கான சிறந்த 10 செயல்திறன் துறை நிதி
துறைபரஸ்பர நிதி ஒரு குறிப்பிட்ட துறைக்குச் சொந்தமான நிறுவனங்களின் பங்கு பங்குகளில் தங்கள் நிதிப் பணத்தின் பெரும்பகுதியை முதலீடு செய்யும் திட்டத்தைப் பார்க்கவும். இந்த திட்டங்கள் தேடும் நபர்களால் தேடப்படுகின்றனஉயர் வருமானம் அவர்களின் முதலீட்டில் ஒருஅதிக ஆபத்து பசியின்மை. மியூச்சுவல் ஃபண்டுகள் பொதுவாக தங்கள் திட்டங்களை வழங்கும் சில துறைகளில் உள்கட்டமைப்பு, மருந்து, வங்கி மற்றும் நிதி சேவைகள் மற்றும் இயற்கை வளங்கள் மற்றும் புதிய ஆற்றல் ஆகியவை அடங்கும். 2019 ஆம் ஆண்டிற்கான துறை நிதிகளின் செயல்திறன் கணிசமாக சிறப்பாக உள்ளது. பொருளாதாரத்தின் வளர்ச்சியுடன், பல துறை நிதிகள் தங்கள் முதலீடுகளுக்கு சாதகமான வருமானத்தை ஈட்டியுள்ளன. எனவே, 2019 ஆம் ஆண்டிற்கான சிறந்த மற்றும் சிறந்த 10 செயல்திறன் துறை மியூச்சுவல் ஃபண்டுகளில் சிலவற்றை அவற்றின் செயல்திறன் (வருமானம்) அடிப்படையில் பார்ப்போம்.
Talk to our investment specialist
செயல்திறனை அடிப்படையாகக் கொண்டு 2019 ஆம் ஆண்டிற்கான சிறந்த 10 செயல்திறன் துறை பரஸ்பர நிதிகள்
Fund NAV Net Assets (Cr) 2024 (%) 2023 (%) 2022 (%) 2021 (%) 2020 (%) LIC MF Infrastructure Fund Growth ₹49.6348
↑ 0.67 ₹1,054 47.8 44.4 7.9 46.6 -0.1 UTI Healthcare Fund Growth ₹289.947
↑ 2.35 ₹1,125 42.9 38.2 -12.3 19.1 67.4 SBI Healthcare Opportunities Fund Growth ₹431.474
↓ -0.01 ₹4,082 42.2 38.2 -6 20.1 65.8 TATA India Pharma & Healthcare Fund Growth ₹30.8448
↑ 0.17 ₹1,325 40.4 36.6 -8 19.1 64.4 Bandhan Infrastructure Fund Growth ₹49.262
↑ 0.57 ₹1,625 39.3 50.3 1.7 64.8 6.3 Franklin India Opportunities Fund Growth ₹259.576
↑ 0.43 ₹8,189 37.3 53.6 -1.9 29.7 27.3 Canara Robeco Infrastructure Growth ₹162.47
↑ 2.22 ₹936 35.3 41.2 9 56.1 9 Nippon India Pharma Fund Growth ₹518.742
↑ 3.97 ₹8,346 34 39.2 -9.9 23.9 66.4 Invesco India Infrastructure Fund Growth ₹61.7
↑ 0.68 ₹1,527 33.2 51.1 2.3 55.4 16.2 Kotak Infrastructure & Economic Reform Fund Growth ₹65.937
↑ 0.69 ₹2,425 32.4 37.3 15.6 57.3 3.4 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 26 Nov 25 Research Highlights & Commentary of 10 Funds showcased
Commentary LIC MF Infrastructure Fund UTI Healthcare Fund SBI Healthcare Opportunities Fund TATA India Pharma & Healthcare Fund Bandhan Infrastructure Fund Franklin India Opportunities Fund Canara Robeco Infrastructure Nippon India Pharma Fund Invesco India Infrastructure Fund Kotak Infrastructure & Economic Reform Fund Point 1 Bottom quartile AUM (₹1,054 Cr). Bottom quartile AUM (₹1,125 Cr). Upper mid AUM (₹4,082 Cr). Lower mid AUM (₹1,325 Cr). Upper mid AUM (₹1,625 Cr). Top quartile AUM (₹8,189 Cr). Bottom quartile AUM (₹936 Cr). Highest AUM (₹8,346 Cr). Lower mid AUM (₹1,527 Cr). Upper mid AUM (₹2,425 Cr). Point 2 Established history (17+ yrs). Oldest track record among peers (26 yrs). Established history (20+ yrs). Established history (9+ yrs). Established history (14+ yrs). Established history (25+ yrs). Established history (20+ yrs). Established history (21+ yrs). Established history (18+ yrs). Established history (17+ yrs). Point 3 Not Rated. Rating: 1★ (lower mid). Rating: 2★ (upper mid). Not Rated. Top rated. Rating: 3★ (upper mid). Not Rated. Rating: 2★ (lower mid). Rating: 3★ (upper mid). Rating: 4★ (top quartile). Point 4 Risk profile: High. Risk profile: High. Risk profile: High. Risk profile: High. Risk profile: High. Risk profile: Moderately High. Risk profile: High. Risk profile: High. Risk profile: High. Risk profile: High. Point 5 5Y return: 28.10% (upper mid). 5Y return: 17.06% (bottom quartile). 5Y return: 18.89% (lower mid). 5Y return: 17.18% (bottom quartile). 5Y return: 29.65% (top quartile). 5Y return: 25.23% (lower mid). 5Y return: 29.40% (top quartile). 5Y return: 17.13% (bottom quartile). 5Y return: 26.80% (upper mid). 5Y return: 28.23% (upper mid). Point 6 3Y return: 26.90% (top quartile). 3Y return: 23.99% (upper mid). 3Y return: 23.87% (lower mid). 3Y return: 22.00% (bottom quartile). 3Y return: 25.19% (upper mid). 3Y return: 28.50% (top quartile). 3Y return: 24.58% (upper mid). 3Y return: 21.68% (bottom quartile). 3Y return: 23.28% (lower mid). 3Y return: 20.82% (bottom quartile). Point 7 1Y return: -1.12% (bottom quartile). 1Y return: 1.77% (lower mid). 1Y return: 1.87% (upper mid). 1Y return: 2.94% (top quartile). 1Y return: -3.01% (bottom quartile). 1Y return: 5.49% (top quartile). 1Y return: 2.89% (upper mid). 1Y return: 2.44% (upper mid). 1Y return: -4.24% (bottom quartile). 1Y return: -0.35% (lower mid). Point 8 Alpha: -6.32 (bottom quartile). Alpha: -0.28 (lower mid). Alpha: -0.29 (lower mid). Alpha: 1.68 (top quartile). Alpha: 0.00 (upper mid). Alpha: 0.68 (top quartile). Alpha: 0.00 (upper mid). Alpha: -2.97 (bottom quartile). Alpha: 0.00 (upper mid). Alpha: -8.58 (bottom quartile). Point 9 Sharpe: -0.04 (upper mid). Sharpe: -0.18 (lower mid). Sharpe: -0.18 (lower mid). Sharpe: -0.28 (bottom quartile). Sharpe: -0.31 (bottom quartile). Sharpe: 0.06 (top quartile). Sharpe: -0.02 (top quartile). Sharpe: -0.35 (bottom quartile). Sharpe: -0.17 (upper mid). Sharpe: -0.14 (upper mid). Point 10 Information ratio: 0.40 (upper mid). Information ratio: 0.00 (upper mid). Information ratio: 0.17 (upper mid). Information ratio: 0.56 (top quartile). Information ratio: 0.00 (lower mid). Information ratio: 1.78 (top quartile). Information ratio: 0.00 (lower mid). Information ratio: -0.76 (bottom quartile). Information ratio: 0.00 (bottom quartile). Information ratio: -0.11 (bottom quartile). LIC MF Infrastructure Fund
UTI Healthcare Fund
SBI Healthcare Opportunities Fund
TATA India Pharma & Healthcare Fund
Bandhan Infrastructure Fund
Franklin India Opportunities Fund
Canara Robeco Infrastructure
Nippon India Pharma Fund
Invesco India Infrastructure Fund
Kotak Infrastructure & Economic Reform Fund
2019 ஆம் ஆண்டிற்கான சிறந்த செயல்திறன் துறை நிதி
The investment objective of the scheme is to provide long term growth from a portfolio of equity / equity related instruments of companies engaged either directly or indirectly in the infrastructure sector. Below is the key information for LIC MF Infrastructure Fund Returns up to 1 year are on (Erstwhile UTI Pharma & Healthcare Fund) The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors. Research Highlights for UTI Healthcare Fund Below is the key information for UTI Healthcare Fund Returns up to 1 year are on (Erstwhile SBI Pharma Fund) To provide the investors maximum growth opportunity through equity
investments in stocks of growth oriented sectors of the economy. Research Highlights for SBI Healthcare Opportunities Fund Below is the key information for SBI Healthcare Opportunities Fund Returns up to 1 year are on The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns. Research Highlights for TATA India Pharma & Healthcare Fund Below is the key information for TATA India Pharma & Healthcare Fund Returns up to 1 year are on The investment objective of the scheme is to seek to generate long-term capital growth through an active diversified portfolio of predominantly equity and equity related instruments of companies that are participating in and benefiting from growth in Indian infrastructure and infrastructural related activities. However, there can be no assurance that the investment objective of the scheme will be realized. Research Highlights for Bandhan Infrastructure Fund Below is the key information for Bandhan Infrastructure Fund Returns up to 1 year are on The investment objective of Franklin India Opportunities Fund (FIOF) is to generate capital appreciation by capitalizing on the long-term growth opportunities in the Indian economy. Research Highlights for Franklin India Opportunities Fund Below is the key information for Franklin India Opportunities Fund Returns up to 1 year are on T o g e n e r a t e income/capital appreciation by investing in equities and equity related instruments of companies in the infrastructure sector. However, there can be no assurance that the investment objective of the scheme will be realized. Research Highlights for Canara Robeco Infrastructure Below is the key information for Canara Robeco Infrastructure Returns up to 1 year are on The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies. Research Highlights for Nippon India Pharma Fund Below is the key information for Nippon India Pharma Fund Returns up to 1 year are on The Scheme seeks to provide long term capital appreciation by investing in a portfolio that is predominantly constituted of equity and equity related instruments of infrastructure companies. However, there can be no assurance that the investment objective of the Scheme will be achieved. Research Highlights for Invesco India Infrastructure Fund Below is the key information for Invesco India Infrastructure Fund Returns up to 1 year are on The investment objective of the Scheme is to generate long-term capital appreciation from a diversified portfolio of predominantly (at least 65%) equity and equity-related securities of companies involved in economic development of India as a result of potential investments in infrastructure and unfolding economic reforms. Research Highlights for Kotak Infrastructure & Economic Reform Fund Below is the key information for Kotak Infrastructure & Economic Reform Fund Returns up to 1 year are on 1. LIC MF Infrastructure Fund
LIC MF Infrastructure Fund
Growth Launch Date 29 Feb 08 NAV (26 Nov 25) ₹49.6348 ↑ 0.67 (1.38 %) Net Assets (Cr) ₹1,054 on 31 Oct 25 Category Equity - Sectoral AMC LIC Mutual Fund Asset Mgmt Co Ltd Rating Risk High Expense Ratio 2.21 Sharpe Ratio -0.04 Information Ratio 0.4 Alpha Ratio -6.32 Min Investment 5,000 Min SIP Investment 1,000 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value Returns for LIC MF Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 26 Nov 25 Duration Returns 1 Month -1.4% 3 Month 3.6% 6 Month 2.9% 1 Year -1.1% 3 Year 26.9% 5 Year 28.1% 10 Year 15 Year Since launch 9.5% Historical performance (Yearly) on absolute basis
Year Returns 2024 47.8% 2023 44.4% 2022 7.9% 2021 46.6% 2020 -0.1% 2019 13.3% 2018 -14.6% 2017 42.2% 2016 -2.2% 2015 -6.2% Fund Manager information for LIC MF Infrastructure Fund
Name Since Tenure Data below for LIC MF Infrastructure Fund as on 31 Oct 25
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 2. UTI Healthcare Fund
UTI Healthcare Fund
Growth Launch Date 28 Jun 99 NAV (26 Nov 25) ₹289.947 ↑ 2.35 (0.82 %) Net Assets (Cr) ₹1,125 on 31 Oct 25 Category Equity - Sectoral AMC UTI Asset Management Company Ltd Rating ☆ Risk High Expense Ratio 2.26 Sharpe Ratio -0.18 Information Ratio 0 Alpha Ratio -0.28 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value Returns for UTI Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 26 Nov 25 Duration Returns 1 Month -0.6% 3 Month -0.7% 6 Month 5.2% 1 Year 1.8% 3 Year 24% 5 Year 17.1% 10 Year 15 Year Since launch 14.8% Historical performance (Yearly) on absolute basis
Year Returns 2024 42.9% 2023 38.2% 2022 -12.3% 2021 19.1% 2020 67.4% 2019 1.2% 2018 -7.5% 2017 6.2% 2016 -9.7% 2015 12.4% Fund Manager information for UTI Healthcare Fund
Name Since Tenure Data below for UTI Healthcare Fund as on 31 Oct 25
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 3. SBI Healthcare Opportunities Fund
SBI Healthcare Opportunities Fund
Growth Launch Date 31 Dec 04 NAV (25 Nov 25) ₹431.474 ↓ -0.01 (0.00 %) Net Assets (Cr) ₹4,082 on 31 Oct 25 Category Equity - Sectoral AMC SBI Funds Management Private Limited Rating ☆☆ Risk High Expense Ratio 1.97 Sharpe Ratio -0.18 Information Ratio 0.17 Alpha Ratio -0.29 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-15 Days (0.5%),15 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value Returns for SBI Healthcare Opportunities Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 26 Nov 25 Duration Returns 1 Month -1.5% 3 Month -1.4% 6 Month 3.3% 1 Year 1.9% 3 Year 23.9% 5 Year 18.9% 10 Year 15 Year Since launch 15.3% Historical performance (Yearly) on absolute basis
Year Returns 2024 42.2% 2023 38.2% 2022 -6% 2021 20.1% 2020 65.8% 2019 -0.5% 2018 -9.9% 2017 2.1% 2016 -14% 2015 27.1% Fund Manager information for SBI Healthcare Opportunities Fund
Name Since Tenure Data below for SBI Healthcare Opportunities Fund as on 31 Oct 25
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 4. TATA India Pharma & Healthcare Fund
TATA India Pharma & Healthcare Fund
Growth Launch Date 28 Dec 15 NAV (26 Nov 25) ₹30.8448 ↑ 0.17 (0.54 %) Net Assets (Cr) ₹1,325 on 31 Oct 25 Category Equity - Sectoral AMC Tata Asset Management Limited Rating Risk High Expense Ratio 2.17 Sharpe Ratio -0.28 Information Ratio 0.56 Alpha Ratio 1.68 Min Investment 5,000 Min SIP Investment 150 Exit Load 0-3 Months (0.25%),3 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value Returns for TATA India Pharma & Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 26 Nov 25 Duration Returns 1 Month -0.4% 3 Month 0% 6 Month 4.7% 1 Year 2.9% 3 Year 22% 5 Year 17.2% 10 Year 15 Year Since launch 12% Historical performance (Yearly) on absolute basis
Year Returns 2024 40.4% 2023 36.6% 2022 -8% 2021 19.1% 2020 64.4% 2019 5.5% 2018 -2.6% 2017 4.7% 2016 -14.7% 2015 Fund Manager information for TATA India Pharma & Healthcare Fund
Name Since Tenure Data below for TATA India Pharma & Healthcare Fund as on 31 Oct 25
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 5. Bandhan Infrastructure Fund
Bandhan Infrastructure Fund
Growth Launch Date 8 Mar 11 NAV (26 Nov 25) ₹49.262 ↑ 0.57 (1.18 %) Net Assets (Cr) ₹1,625 on 31 Oct 25 Category Equity - Sectoral AMC IDFC Asset Management Company Limited Rating ☆☆☆☆☆ Risk High Expense Ratio 2.1 Sharpe Ratio -0.31 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 100 Exit Load 0-365 Days (1%),365 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value Returns for Bandhan Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 26 Nov 25 Duration Returns 1 Month -1.6% 3 Month 0.3% 6 Month -2.1% 1 Year -3% 3 Year 25.2% 5 Year 29.6% 10 Year 15 Year Since launch 11.4% Historical performance (Yearly) on absolute basis
Year Returns 2024 39.3% 2023 50.3% 2022 1.7% 2021 64.8% 2020 6.3% 2019 -5.3% 2018 -25.9% 2017 58.7% 2016 10.7% 2015 -0.2% Fund Manager information for Bandhan Infrastructure Fund
Name Since Tenure Data below for Bandhan Infrastructure Fund as on 31 Oct 25
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 6. Franklin India Opportunities Fund
Franklin India Opportunities Fund
Growth Launch Date 21 Feb 00 NAV (25 Nov 25) ₹259.576 ↑ 0.43 (0.17 %) Net Assets (Cr) ₹8,189 on 31 Oct 25 Category Equity - Sectoral AMC Franklin Templeton Asst Mgmt(IND)Pvt Ltd Rating ☆☆☆ Risk Moderately High Expense Ratio 1.83 Sharpe Ratio 0.06 Information Ratio 1.78 Alpha Ratio 0.68 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value Returns for Franklin India Opportunities Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 26 Nov 25 Duration Returns 1 Month -0.6% 3 Month 1% 6 Month 5.7% 1 Year 5.5% 3 Year 28.5% 5 Year 25.2% 10 Year 15 Year Since launch 13.5% Historical performance (Yearly) on absolute basis
Year Returns 2024 37.3% 2023 53.6% 2022 -1.9% 2021 29.7% 2020 27.3% 2019 5.4% 2018 -10.1% 2017 35.6% 2016 4.2% 2015 2.3% Fund Manager information for Franklin India Opportunities Fund
Name Since Tenure Data below for Franklin India Opportunities Fund as on 31 Oct 25
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 7. Canara Robeco Infrastructure
Canara Robeco Infrastructure
Growth Launch Date 2 Dec 05 NAV (26 Nov 25) ₹162.47 ↑ 2.22 (1.39 %) Net Assets (Cr) ₹936 on 31 Oct 25 Category Equity - Sectoral AMC Canara Robeco Asset Management Co. Ltd. Rating Risk High Expense Ratio 2.32 Sharpe Ratio -0.02 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 1,000 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value Returns for Canara Robeco Infrastructure
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 26 Nov 25 Duration Returns 1 Month -0.2% 3 Month 2.9% 6 Month 3.5% 1 Year 2.9% 3 Year 24.6% 5 Year 29.4% 10 Year 15 Year Since launch 15% Historical performance (Yearly) on absolute basis
Year Returns 2024 35.3% 2023 41.2% 2022 9% 2021 56.1% 2020 9% 2019 2.3% 2018 -19.1% 2017 40.2% 2016 2.1% 2015 6.7% Fund Manager information for Canara Robeco Infrastructure
Name Since Tenure Data below for Canara Robeco Infrastructure as on 31 Oct 25
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 8. Nippon India Pharma Fund
Nippon India Pharma Fund
Growth Launch Date 5 Jun 04 NAV (26 Nov 25) ₹518.742 ↑ 3.97 (0.77 %) Net Assets (Cr) ₹8,346 on 31 Oct 25 Category Equity - Sectoral AMC Nippon Life Asset Management Ltd. Rating ☆☆ Risk High Expense Ratio 1.81 Sharpe Ratio -0.35 Information Ratio -0.76 Alpha Ratio -2.97 Min Investment 5,000 Min SIP Investment 100 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value Returns for Nippon India Pharma Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 26 Nov 25 Duration Returns 1 Month 0.9% 3 Month 0.9% 6 Month 2.9% 1 Year 2.4% 3 Year 21.7% 5 Year 17.1% 10 Year 15 Year Since launch 20.2% Historical performance (Yearly) on absolute basis
Year Returns 2024 34% 2023 39.2% 2022 -9.9% 2021 23.9% 2020 66.4% 2019 1.7% 2018 3.6% 2017 7.6% 2016 -10.6% 2015 19.4% Fund Manager information for Nippon India Pharma Fund
Name Since Tenure Data below for Nippon India Pharma Fund as on 31 Oct 25
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 9. Invesco India Infrastructure Fund
Invesco India Infrastructure Fund
Growth Launch Date 21 Nov 07 NAV (26 Nov 25) ₹61.7 ↑ 0.68 (1.11 %) Net Assets (Cr) ₹1,527 on 31 Oct 25 Category Equity - Sectoral AMC Invesco Asset Management (India) Private Ltd Rating ☆☆☆ Risk High Expense Ratio 2.09 Sharpe Ratio -0.17 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value Returns for Invesco India Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 26 Nov 25 Duration Returns 1 Month -3.2% 3 Month -2.4% 6 Month -3% 1 Year -4.2% 3 Year 23.3% 5 Year 26.8% 10 Year 15 Year Since launch 10.6% Historical performance (Yearly) on absolute basis
Year Returns 2024 33.2% 2023 51.1% 2022 2.3% 2021 55.4% 2020 16.2% 2019 6.1% 2018 -15.8% 2017 48.1% 2016 0.8% 2015 -2.6% Fund Manager information for Invesco India Infrastructure Fund
Name Since Tenure Data below for Invesco India Infrastructure Fund as on 31 Oct 25
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 10. Kotak Infrastructure & Economic Reform Fund
Kotak Infrastructure & Economic Reform Fund
Growth Launch Date 25 Feb 08 NAV (26 Nov 25) ₹65.937 ↑ 0.69 (1.05 %) Net Assets (Cr) ₹2,425 on 31 Oct 25 Category Equity - Sectoral AMC Kotak Mahindra Asset Management Co Ltd Rating ☆☆☆☆ Risk High Expense Ratio 2.01 Sharpe Ratio -0.14 Information Ratio -0.11 Alpha Ratio -8.58 Min Investment 5,000 Min SIP Investment 1,000 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value Returns for Kotak Infrastructure & Economic Reform Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 26 Nov 25 Duration Returns 1 Month -0.6% 3 Month 2.6% 6 Month 2.2% 1 Year -0.4% 3 Year 20.8% 5 Year 28.2% 10 Year 15 Year Since launch 11.2% Historical performance (Yearly) on absolute basis
Year Returns 2024 32.4% 2023 37.3% 2022 15.6% 2021 57.3% 2020 3.4% 2019 3.6% 2018 -19.6% 2017 45.3% 2016 9.2% 2015 -0.2% Fund Manager information for Kotak Infrastructure & Economic Reform Fund
Name Since Tenure Data below for Kotak Infrastructure & Economic Reform Fund as on 31 Oct 25
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity
இங்கு வழங்கப்பட்ட தகவல்கள் துல்லியமானவை என்பதை உறுதிப்படுத்த அனைத்து முயற்சிகளும் மேற்கொள்ளப்பட்டுள்ளன. இருப்பினும், தரவின் சரியான தன்மை குறித்து எந்த உத்தரவாதமும் அளிக்கப்படவில்லை. எந்தவொரு முதலீடும் செய்வதற்கு முன் திட்ட தகவல் ஆவணத்துடன் சரிபார்க்கவும்.
You Might Also Like
AMFI Registration No. 112358 | CIN: U74999MH2016PTC282153
Shepard Technologies Pvt. Ltd. (with ARN code 112358) makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Terms and conditions of the website are applicable.
©2025 Shepard Technologies Private Limited. All Rights Reserved
Research Highlights for LIC MF Infrastructure Fund